BIODESIX INC — Director's Dealing 2022

Jan 4, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2021-12-30

Reporting Person: Strobeck Matthew (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-30	Common Stock	P	138700	$4.35	Acquired	211200	Indirect
2021-12-30	Common Stock	P	9100	$4.35	Acquired	19933	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	966883	Direct
Common Stock	3518	Indirect
Common Stock	3518	Indirect
Common Stock	3518	Indirect
Common Stock	3518	Indirect
Common Stock	40665	Indirect

Footnotes

F1: The reporting person has sole voting and dispositive power with respect to shares held by Birchview Fund, LLC and the Birchview Capital Separately Managed Account in his capacity as Managers of such entities. The shares reported herein as held by Birchview Fund, LLC and the shares reported held by Birchview Capital Separately Managed Account were always held for each respective account, but were inadvertently reported as all being held for Birchview Fund, LLC in the Form 4 filed on November 3, 2020. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

F2: The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

F3: The reporting person is an affiliate of Clajer Capital LLC. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

F4: In the Form 4 filed by the reporting person on November 3, 2020, and each subsequent Form 4, the Amount of Securities Beneficially Owned reported in Table I as directly held was inadvertently overstated by 92 shares. This Form 4 corrects, in Table I, the Amount of Securities Beneficially Owned directly by the reporting person.

F5: In the Form 4 filed by the reporting person on November 3, 2020, and each subsequent Form 4, the Amount of Securities Beneficially Owned reported in Table I as held by each UGMA Account was inadvertently overstated by 4 shares. This Form 4 corrects, in Table I, the Amount of Securities Beneficially Owned by each UGMA Account.

F6: In the Form 4 filed by the reporting person on November 3, 2020, and each subsequent Form 4, the Amount of Securities Beneficially Owned reported in Table I as held by Clajer Capital LLC was inadvertently overstated by 22 shares. This Form 4 corrects, in Table I, the Amount of Securities Beneficially Owned by Clajer Capital LLC.